Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

In vivo transduction of thymic dendritic cells with adenovirus and its potential use in acute inflammatory diseases.

Oberholzer C, Tschoeke SK, Bahjat K, LaFace D, Hutchins B, Clare-Salzler MJ, Moldawer LL, Oberholzer A.

Scand J Immunol. 2005 Apr;61(4):309-15.

2.

Increased survival in sepsis by in vivo adenovirus-induced expression of IL-10 in dendritic cells.

Oberholzer A, Oberholzer C, Bahjat KS, Ungaro R, Tannahill CL, Murday M, Bahjat FR, Abouhamze Z, Tsai V, LaFace D, Hutchins B, Moldawer LL, Clare-Salzler MJ.

J Immunol. 2002 Apr 1;168(7):3412-8.

3.

Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.

Satoh E, Li XK, Hara Y, Ogata K, Guo L, Kitazawa Y, Funeshima-Fuji N, Satoh T, Miyagi T, Sugiura W, Yamamoto N, Teramoto K, Arii S, Kimura H.

Transpl Immunol. 2007 Nov;18(2):73-84. Epub 2007 Jun 6.

PMID:
18005848
4.

Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis.

Oberholzer A, Oberholzer C, Efron PA, Scumpia PO, Uchida T, Bahjat K, Ungaro R, Tannahill CL, Murday M, Bahjat FR, Tsai V, Hutchins B, Moldawer LL, Laface D, Clare-Salzler MJ.

Shock. 2005 Jun;23(6):507-15.

PMID:
15897802
5.

Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.

Mercier S, Gahéry-Segard H, Monteil M, Lengagne R, Guillet JG, Eloit M, Denesvre C.

J Virol. 2002 Mar;76(6):2899-911.

7.

Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC.

van Leeuwen EB, Cloosen S, Senden-Gijsbers BL, Germeraad WT, Bos GM.

Cytotherapy. 2006;8(1):36-46.

PMID:
16627343
8.

Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity.

Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Miyagi T, Jinushi M, Sakamori R, Kohga K, Uemura A, Ohkawa K, Storkus WJ, Hayashi N.

Gene Ther. 2007 Jun;14(11):863-71. Epub 2007 Mar 8.

PMID:
17344900
9.

Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.

Aldrich WA, Ren C, White AF, Zhou SZ, Kumar S, Jenkins CB, Shaw DR, Strong TV, Triozzi PL, Ponnazhagan S.

Gene Ther. 2006 Jan;13(1):29-39.

PMID:
16136165
10.

The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.

Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.

Int J Oncol. 2006 Apr;28(4):947-53.

PMID:
16525645
11.

Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.

Harui A, Roth MD, Kiertscher SM, Mitani K, Basak SK.

Gene Ther. 2004 Nov;11(22):1617-26.

PMID:
15295617
12.

Generation of anti-tumor response by JAWS II mouse dendritic cells transduced with murine interleukin 12 genes.

Pajtasz-Piasecka E, Rossowska J, Szyda A, Krawczenko A, Dus D.

Oncol Rep. 2007 May;17(5):1249-57.

PMID:
17390073
13.

Tumour antigen-loaded mouse dendritic cells maturing in the presence of inflammatory cytokines are potent activators of immune response in vitro but not in vivo.

Rossowska J, Pajtasz-Piasecka E, Szyda A, Krawczenko A, Zietara N, Dus D.

Oncol Rep. 2009 Jun;21(6):1539-49.

PMID:
19424635
14.

Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.

Oh ST, Kim CH, Park MY, Won EH, Sohn HJ, Cho HI, Kang WK, Hong YK, Kim TG.

Vaccine. 2006 Apr 5;24(15):2860-8. Epub 2006 Jan 13.

PMID:
16443309
15.

Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice.

Chen L, Tang XD, Yu ST, Ai ZH, Fang DC, Cai YG, Luo YH, Liang GP, Yang SM.

J Pathol. 2009 Apr;217(5):685-92. doi: 10.1002/path.2493.

PMID:
19142972
16.

Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.

Nukiwa M, Andarini S, Zaini J, Xin H, Kanehira M, Suzuki T, Fukuhara T, Mizuguchi H, Hayakawa T, Saijo Y, Nukiwa T, Kikuchi T.

Eur J Immunol. 2006 Apr;36(4):1019-27.

17.

Combined mobilization and stimulation of tumor-infiltrating dendritic cells and natural killer cells with Flt3 ligand and IL-18 in vivo induces systemic antitumor immunity.

Saito T, Takayama T, Osaki T, Nagai S, Suzuki T, Sato M, Kuwano H, Tahara H.

Cancer Sci. 2008 Oct;99(10):2028-36. doi: 10.1111/j.1349-7006.2008.00907.x.

18.

Novel centrifugal method for simple and highly efficient adenovirus-mediated green fluorescence protein gene transduction into human monocyte-derived dendritic cells.

Nishimura N, Nishioka Y, Shinohara T, Ogawa H, Yamamoto S, Tani K, Sone S.

J Immunol Methods. 2001 Jul 1;253(1-2):113-24.

PMID:
11384673
19.

Innate immune responses to adenoviral vector-mediated acute pancreatitis.

Shifrin AL, Chirmule N, Gao GP, Wilson JM, Raper SE.

Pancreas. 2005 Mar;30(2):122-9.

PMID:
15714134
20.

Supplemental Content

Support Center